OA18.03 Alum-adjuvanted protein administered in combination with ALVAC-HIV downregulates early serum cytokine responses to the vaccine whereas MF59 enhances the early cytokine burstOral Abstract SessionImplementation science, including structural interventions, PrEP & VMMC
OA20.01 Alternative T cell effector functions are linked to humoral responses to HIV infectionOral Abstract SessionCellular immunity
PE11.03 Age-Disparate Sex Partnerships and HIV Infection among Adolescent Girls and Young Women in MalawiE-posterDiscovery and evaluation of biomedical agents
OA10.03 Advocates' perspectives on an efficacy trial of F/TAF as PrEP for womenOral Abstract SessionCommunity engagement in prevention research
PE21.04LB Advances in the use of a bacterially derived glycoside for inducing oligomannose-targeted neutralizing antibodies to HIV-1E-posterNovel vaccine and other prevention approaches
PE23.02 Adoption of WHO's HIV retesting policy for HIV-negative women during the breastfeeding period in 10 high HIV-burden African countriesE-posterPolicy and advocacy
PE01.31 Adolescent girls and young women's (AGYW) PrEP-user journey during an implementation science study in South Africa and KenyaE-posterBehavioural and social science research
PE16.10 Adherence to the event-driven PrEP regimen within the Amsterdam PrEP demonstration project: analysis based on online diary dataE-posterHumoral immunity
OA05.02 Acute SIV Induces BHLH gene variants prior to adaptive natural killer cell formationOral Abstract SessionInnate and trained immunity
PE20.06 Acute sexual violence exposure dysregulates HIV associated cervical immune biomarkers in womenE-posterMucosal immunity
seek-warrow-warrow-eseek-e421 - 430 of 444 items